Reuters: Health
A cancer drug from AstraZeneca and Merck helped men with advanced prostate cancer and certain genetic mutations live longer in a late-stage study investigating its effectiveness, the British company said on Friday.
AstraZeneca's Lynparza shows further promise in prostate cancer study
AstraZeneca's Lynparza shows further promise in prostate cancer study
Reuters: Health
A cancer drug from AstraZeneca and Merck helped men with advanced prostate cancer and certain genetic mutations live longer in a late-stage study investigating its effectiveness, the British company said on Friday.
Reuters: Health
A cancer drug from AstraZeneca and Merck helped men with advanced prostate cancer and certain genetic mutations live longer in a late-stage study investigating its effectiveness, the British company said on Friday.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment